Organigram Announces Appointment of Chief Executive Officer

Executive Summary

• Organigram Global Inc. announced the appointment of James Yamanaka, former Global Head of Strategy at British American Tobacco, as its new CEO effective around January 15 2026.
• Yamanaka will also join the Board of Directors upon assuming the CEO role; interim executive chair Peter Amirault will oversee day‑to‑day management until then.
• The appointment is positioned to support Organigram’s strategy of expanding its international presence and accelerating growth in the global cannabis market.

Key Details

• New CEO: James Yamanaka, previously Global Head of Strategy at BAT; over 20 years of experience in strategy and general management across Europe and Asia.
• Effective Date: On or about January 15 2026 (subject to immigration and security clearance procedures).
• Board Membership: Yamanaka will become a member of Organigram’s Board of Directors when he assumes the CEO role.
• Interim Management:
• Peter Amirault, current Board chairman, appointed Executive Chair effective December 1 2025 to oversee daily operations until Yamanaka starts.
• Geoff Machum, chair of the Governance, Nominating and Sustainability Committee, will serve as Independent Lead Director during the interim period.
• Strategic Rationale: Management highlighted Yamanaka’s track record in driving international growth, building high‑performing teams, and delivering results—key to Organigram’s ambition to become a global leader in cannabis.
• CEO Quote: “I am thrilled to take on this new challenge… I look forward to building an international presence on Organigram’s strong foundation of high‑quality products, trusted brands, and a commitment to industry‑leading innovation.” – James Yamanaka.
• Chair Quote: “James’ history of driving strong international growth aligns perfectly with Organigram’s global aspirations.” – Peter Amirault.

Notable Quotes

• “We are excited to have James join the Organigram team,” said Peter Amirault, Board Chairman and interim Executive Chair.
• “I have watched Organigram evolve into Canada’s number one recreational cannabis company by market share and believe it is well positioned to become a global leader in the cannabis industry.” – James Yamanaka.